 |
| 21-Jan-10 | Initiated |
Jefferies & Co |
Hold |
$21 |
|
| 30-Jul-09 | Initiated |
Maxim Group |
Hold |
|
|
| 15-Jul-09 | Initiated |
Avondale |
Mkt Perform |
$14 |
|
| 09-Jun-09 | Initiated |
Leerink Swann |
Mkt Perform |
|
|
| 27-Mar-09 | Initiated |
Northland Securities |
Market Perform |
$26.50 |
|
| 15-Dec-08 | Reiterated |
Robert W. Baird |
Outperform |
$33 → $31 |
|
| 19-Mar-08 | Initiated |
Susquehanna Financial |
Positive |
|
|
| 04-Oct-07 | Reiterated |
Robert W. Baird |
Outperform |
$39 → $43 |
|
|
|
| 03-Feb-10 07:06AM | 3 Best Hedge Fund Healthcare Ideas at Seeking Alpha |
| 27-Jan-10 02:16PM | Capital Requirements Increase In Diagnostic And Lab Equipment Sector: Northland Securities Industry Expert Picks The Stock Winners And Losers Wall Street Transcript |
| 21-Jan-10 02:01AM | Coverage initiated on Immucor by Jefferies & Co Briefing.com |
| 13-Jan-10 01:04PM | IMMUCOR INC Financials EDGAR Online Financials |
| 11-Jan-10 12:43PM | The 10 Most-Loved Stocks of 2009 at Motley Fool |
| 08-Jan-10 08:11AM | Immucor, Inc.: Warming Up or Cooling Off? at Motley Fool |
| 07-Jan-10 01:44PM | IMMUCOR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 01:09PM | Immucor, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript at Seeking Alpha |
| 09:25AM | New Star Analyst Rankings for Immucor, Inc. StarMine |
| 03:58AM | Bridger: Another Hedge Fund Going Very Long at Seeking Alpha |
| 06-Jan-10 06:40PM | Immucor Results Beat Expectations at Fox Business |
| 06:29PM | Earnings roundup: Monsanto, Shaw Group AP |
| 05:06PM | UPDATE - Immucor Q2 profit beats Street view, backs '10 view at Reuters |
| 04:56PM | Immucor 2Q profit rises 14 percent on sales boost AP |
| 04:45PM | Immucor second-quarter profit rises to $19.7 mln at MarketWatch |
| 04:14PM | InPlay: Immucor beats by $0.02, beats on revs; reaffirms FY10 EPS guidance, revs guidance Briefing.com |
| 04:01PM | Immucor Announces Fiscal Second Quarter Results PR Newswire |
| 04-Jan-10 04:01PM | Immucor to Present at the 28th Annual J.P. Morgan Healthcare Conference PR Newswire |
| 10:29AM | 7 Reasons Not to Worry This Week at Motley Fool |
| 23-Dec-09 03:55AM | In Search of the Next See's Candies: 4 Small Caps to Consider at Seeking Alpha |
| 22-Dec-09 12:16PM | The Search for the Next See's Candies at Motley Fool |
| 19-Dec-09 05:49AM | [$$] 13D Filings at Barrons.com |
| 16-Dec-09 05:05PM | Mintz joins Immucor board at bizjournals.com |
| 04:46PM | Immucor names Dr. Paul Mintz to board of directors AP |
| 04:22PM | IMMUCOR INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04:01PM | Immucor Appoints New Board Director PR Newswire |
| 15-Dec-09 04:01PM | Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010 PR Newswire |
| 07-Dec-09 01:14PM | Today's 5-Star Movers at Motley Fool |
| 23-Nov-09 05:23PM | Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference PR Newswire |
| 13-Nov-09 08:50AM | Piper Jaffray Sees Pharma M&A Activity Continuing Wall Street Transcript |
| 26-Oct-09 12:18PM | 10 Companies that Just 'Keep a-Comin' at Seeking Alpha |
| 07-Oct-09 05:19PM | Immucor Inc. Q1 2010 Earnings Call Transcript at Seeking Alpha |
| 05-Oct-09 08:23AM | Immucor Beats Estimates Zacks.com |
| 02-Oct-09 03:16PM | IMMUCOR INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:18AM | The Pomerantz Firm Charges Immucor, Inc. With Securities Fraud -- BLUD GlobeNewswire |
| 01-Oct-09 08:25PM | [video] Accenture's Sales Drop at Forbes.com |
| 06:35PM | Immucor Profit, Revenue Rise in 1Q at Fox Business |
| 06:10PM | Earnings roundup: Global Payments, Immucor AP |
| 05:10PM | Immucor 1Q profit rises 7 percent on sales boost AP |
| 05:05PM | Immucor net income rises at bizjournals.com |
| 04:28PM | IMMUCOR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:24PM | Immucor first-quarter profit rises to $21.3 mln at MarketWatch |
| 04:05PM | Immucor Announces Fiscal First Quarter Results PR Newswire |
| 07:07AM | Q1 2010 Immucor Earnings Release - After Market Close CCBN |
| 30-Sep-09 06:26PM | Stocks to Watch: Stocks in focus for Thursday at MarketWatch |
| 04:51PM | Weekly Jobless Claims: Tomorrow's Headliners at TheStreet.com |
| 04:51PM | Jobless Claims: Tomorrow's Headliners at TheStreet.com |
| 07:00AM | 4 Ideas for the Coming Rally at Motley Fool |
| 28-Sep-09 02:31PM | The Best Stocks for the Next 4 Years at Motley Fool |
| 25-Sep-09 04:20PM | Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Immucor, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the October 26, 2009 Lead Plaintiff Deadli Marketwire |
| 22-Sep-09 06:00PM | Shareholder Class Action Filed Against Immucor, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP PR Newswire |
| 17-Sep-09 04:01PM | Immucor to Announce Fiscal First Quarter Financial Results on Thursday, October 1, 2009 PR Newswire |
| 02:40PM | 5-Star Stocks on the Upswing at Motley Fool |
| 11:59AM | Bronstein, Gewirtz & Grossman, LLC Announces Class Action Lawsuit Against Immucor, Inc. Marketwire |
| 16-Sep-09 02:39PM | Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Immucor, Inc. - BLUD Marketwire |
| 15-Sep-09 12:33PM | The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Immucor, Inc. GlobeNewswire |
| 08-Sep-09 05:48PM | Immucor to Present at Upcoming Investor Conferences PR Newswire |
| 31-Aug-09 04:02PM | IMMUCOR INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 01:44PM | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Immucor, Inc. (NASDAQ: BLUD) Marketwire |
| 30-Aug-09 05:45AM | Jana Partners Keeps Shedding Convergys Shares at Seeking Alpha |
| 27-Aug-09 07:52PM | Shalov Stone Bonner & Rocco LLP Announces Class Action Against Immucor, Inc. Marketwire |
| 07:05PM | Notice of Filing Securities Class Action Against Immucor, Inc. Business Wire |
| 18-Aug-09 06:05PM | Immunocor expands stock buyback authorization AP |
| 04:13PM | IMMUCOR INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04:10PM | Immucor Announces 2 Million Share Increase to Stock Repurchase Program PR Newswire |
| 10-Aug-09 05:40PM | Immucor sends 30-day inspection response to FDA AP |
| 04:21PM | Immucor Submits 30-Day Response to FDA; Organizational Realignment Supports Quality Initiatives PR Newswire |
| 08-Aug-09 07:51AM | [$$] 13D Filings at Barron's Online |
| 24-Jul-09 03:42PM | IMMUCOR INC Files SEC form 10-K, Annual Report EDGAR Online |
| 02:52PM | Immucor Inc., F4Q09 (Qtr End 05/31/09) Earnings Call Transcript at Seeking Alpha |
| 11:37AM | Immucor Posts Record Revenues in FY09 Zacks.com |
| 07:17AM | Wall Street Breakfast: Must-Know News at Seeking Alpha |
| 07:05AM | Immucor ends fiscal 09 with $76M profit at bizjournals.com |
| 23-Jul-09 04:23PM | IMMUCOR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | Immucor Announces Fiscal Fourth Quarter Results PR Newswire |
| 09:56AM | 4-Star Stocks Poised to Pop: Immucor at Motley Fool |
| 07:07AM | Q4 2009 Immucor Earnings Release - After Market Close CCBN |
| 20-Jul-09 05:30AM | 3 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week at Seeking Alpha |
| 17-Jul-09 08:05AM | Immucor names new COO at bizjournals.com |
| 16-Jul-09 05:58PM | Immucor names Crouse chief operating officer AP |
| 04:38PM | Immucor names Geoffrey Crouse v.p., COO at MarketWatch |
| 04:22PM | IMMUCOR INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 04:15PM | Immucor Appoints Chief Operating Officer PR Newswire |
| 15-Jul-09 04:56PM | Immucor Replies to FDA Notice Zacks.com |
| 11:17AM | Diagnosis Cycle Time Efficiency and Disruptive Technology Key to Point-of-Care Blood Chemistry Company Success Wall Street Transcript |
| 13-Jul-09 05:21PM | Immucor responds to FDA license concerns AP |
| 05:05PM | Immucor responds to FDA at bizjournals.com |
| 04:05PM | Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department PR Newswire |
| 12:49PM | Proteomics Testing Replaces Genomics as Newest Technology to be Deployed in Medical Diagnostics: Industry Leaders Chosen by Experienced Market Analysts Wall Street Transcript |
| 12-Jul-09 06:45AM | Contrarian Stock Screen: Biggest Losers in 2009 at Seeking Alpha |
| 10-Jul-09 11:15AM | These 5 Underdogs Are No Dogs at Motley Fool |
| 07:58AM | RothmanResearch.com Stock Review for MSCC, PAYX, BLUD, PCAR, APOL and SSRI Marketwire |
| 09-Jul-09 08:30AM | Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009 PR Newswire |
| 08-Jul-09 01:55PM | 5 Stocks Making Cash at Motley Fool |
| 11:11AM | Jana Partners Reduces Its Stake in Coleman Cable at Seeking Alpha |
| 02-Jul-09 06:15AM | Zacks #5 Rank Additions for Thursday Zacks.com |
| 30-Jun-09 06:45AM | Immucor Gets FDA Notice to Revoke Biologics License Zacks.com |
| 27-Jun-09 05:46AM | [$$] Charting The Market at Barron's Online |
| 26-Jun-09 11:33PM | [$$] Scripps, CACI Gain; KB Slides at The Wall Street Journal Online -14.23% |
| 05:11PM | [$$] Stocks in the Spotlight Friday at Barron's Online |
|
|
| Immucor, Inc., an in vitro diagnostics company, engages in the development, manufacture, and sale of reagents and automated systems. Its products are used by hospitals, reference laboratories, and donor centers to detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. The company's reagent products are used in tests to identify blood group and type; to detect and identify red cell antibodies or red cell antigens; to detect and identify platelet antibodies; and to determine blood compatibility. It offers various test systems, including Capture-P, a platelet antibody detection system; Capture-R, a red cell antibody detection system; Capture-R Select, which is used for antibody screening, identification, phenotyping, cross matching, and in the weak D test; and Capture-CMV and Capture-S, which are tests for infectious diseases. Immucor, Inc. also offers automated analyzers comprising Galileo, which provides an automated solution to perform various routine blood bank tests, such as blood grouping, antibody screening, crossmatch, direct antiglobulin test, antibody identification, and cytomegalovirus and syphilis screening; Galileo Echo, a compact bench top automated instrument for the small to medium-sized hospitals, and blood banks; and Capture Workstation, a semi-automated processor, which has semi-automated components for performing capture assays manually. The company offers its medical instruments on rent. It sells its products directly in the United States, Canada, western Europe, and Japan; and through distributors internationally. The company was founded in 1982 and is based in Norcross, Georgia. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| EATZ RALPH A | Chief Scientific Officer | Apr 07 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Apr 09 04:25 PM | | EATZ RALPH A | Chief Scientific Officer | Apr 07 | Sale | 25.95 | 10,000 | 259,500 | 304,816 | Apr 09 04:25 PM | | EATZ RALPH A | Chief Scientific Officer | Mar 31 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Apr 01 04:28 PM | | EATZ RALPH A | Chief Scientific Officer | Mar 31 | Sale | 25.00 | 10,000 | 250,000 | 304,816 | Apr 01 04:28 PM | | EATZ RALPH A | Chief Scientific Officer | Mar 24 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Mar 26 03:14 PM | | EATZ RALPH A | Chief Scientific Officer | Mar 24 | Sale | 25.08 | 10,000 | 250,750 | 304,816 | Mar 26 03:14 PM | | EATZ RALPH A | Chief Scientific Officer | Feb 24 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Feb 26 10:43 AM | | EATZ RALPH A | Chief Scientific Officer | Feb 24 | Sale | 25.12 | 10,000 | 251,237 | 304,816 | Feb 26 10:43 AM | | EATZ RALPH A | Chief Scientific Officer | Feb 17 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Feb 19 04:33 PM | | EATZ RALPH A | Chief Scientific Officer | Feb 17 | Sale | 26.98 | 10,000 | 269,767 | 304,816 | Feb 19 04:33 PM | | EATZ RALPH A | Chief Scientific Officer | Feb 10 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Feb 12 03:45 PM | | EATZ RALPH A | Chief Scientific Officer | Feb 10 | Sale | 27.67 | 10,000 | 276,685 | 304,816 | Feb 12 03:45 PM | | EATZ RALPH A | Chief Scientific Officer | Feb 03 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Feb 04 10:45 AM | | EATZ RALPH A | Chief Scientific Officer | Feb 03 | Sale | 27.97 | 10,000 | 279,676 | 304,816 | Feb 04 10:45 AM | | EATZ RALPH A | Chief Scientific Officer | Jan 27 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Jan 28 02:15 PM | | EATZ RALPH A | Chief Scientific Officer | Jan 27 | Sale | 28.01 | 10,000 | 280,124 | 304,816 | Jan 28 02:15 PM | | EATZ RALPH A | Chief Scientific Officer | Jan 20 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Jan 21 09:47 AM | | EATZ RALPH A | Chief Scientific Officer | Jan 20 | Sale | 27.67 | 10,000 | 276,749 | 304,816 | Jan 21 09:47 AM | | EATZ RALPH A | Chief Scientific Officer | Jan 13 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Jan 14 02:33 PM | | EATZ RALPH A | Chief Scientific Officer | Jan 13 | Sale | 26.81 | 10,000 | 268,084 | 304,816 | Jan 14 02:33 PM | | EATZ RALPH A | Chief Scientific Officer | Jan 06 | Option Exercise | 0.89 | 10,000 | 8,890 | 314,816 | Jan 08 02:15 PM | | EATZ RALPH A | Chief Scientific Officer | Jan 06 | Sale | 25.16 | 10,000 | 251,583 | 304,816 | Jan 08 02:15 PM |
|
|
|
|
|
|
